Health Care·Health Care Equipment·$13.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.26 | N/A | -312.70% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.26 | N/A | -312.70% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management's tone was defensive, highlighting the difficulties faced during the quarter. They did not provide specific guidance, indicating uncertainty about future performance.
Management did not provide specific revenue figures or guidance for the upcoming quarters.
The company acknowledged challenges but emphasized their commitment to long-term growth.
Insulet Corp's earnings report shows a significant miss on EPS, which typically raises concerns among investors. However, the stock reacted positively, increasing by 1.65%. This could indicate that investors are optimistic about the company's long-term potential despite the current challenges.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CADENCE DESIGN SYS I
Feb 22, 2021